Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroblastoma | 6 | 2015 | 399 | 1.050 |
Why?
|
| Aurora Kinase A | 2 | 2014 | 11 | 0.920 |
Why?
|
| Telemedicine | 1 | 2022 | 188 | 0.670 |
Why?
|
| Azepines | 2 | 2015 | 25 | 0.580 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 541 | 0.440 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 557 | 0.410 |
Why?
|
| Carcinogenesis | 1 | 2014 | 213 | 0.400 |
Why?
|
| Neovascularization, Pathologic | 2 | 2013 | 364 | 0.400 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 286 | 0.380 |
Why?
|
| Pyrimidines | 1 | 2013 | 374 | 0.370 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 605 | 0.330 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 2415 | 0.260 |
Why?
|
| Cell Line, Tumor | 6 | 2015 | 2565 | 0.230 |
Why?
|
| Social Determinants of Health | 1 | 2022 | 102 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 1276 | 0.180 |
Why?
|
| Duodenostomy | 1 | 2018 | 2 | 0.160 |
Why?
|
| Duodenal Obstruction | 1 | 2018 | 4 | 0.160 |
Why?
|
| Intestinal Atresia | 1 | 2018 | 6 | 0.160 |
Why?
|
| Duodenum | 1 | 2018 | 103 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 422 | 0.150 |
Why?
|
| Cell Hypoxia | 2 | 2015 | 171 | 0.140 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2013 | 69 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2014 | 126 | 0.130 |
Why?
|
| Pandemics | 1 | 2022 | 775 | 0.130 |
Why?
|
| RNA Interference | 2 | 2014 | 376 | 0.130 |
Why?
|
| Cell Adhesion | 2 | 2013 | 426 | 0.130 |
Why?
|
| Receptors, Bombesin | 1 | 2015 | 2 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 424 | 0.120 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2014 | 12 | 0.120 |
Why?
|
| Triazoles | 1 | 2015 | 104 | 0.120 |
Why?
|
| Neurogenesis | 1 | 2015 | 77 | 0.120 |
Why?
|
| Pediatrics | 1 | 2018 | 357 | 0.120 |
Why?
|
| Glycolysis | 1 | 2015 | 135 | 0.120 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2013 | 37 | 0.110 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2013 | 4 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2014 | 273 | 0.110 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 88 | 0.110 |
Why?
|
| Cell Movement | 2 | 2014 | 785 | 0.110 |
Why?
|
| Child | 2 | 2022 | 7197 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 282 | 0.110 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 313 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 137 | 0.100 |
Why?
|
| Transfection | 1 | 2014 | 911 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 887 | 0.100 |
Why?
|
| Cell Division | 1 | 2013 | 696 | 0.100 |
Why?
|
| Protein Transport | 1 | 2013 | 421 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 449 | 0.100 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 996 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1654 | 0.090 |
Why?
|
| Humans | 9 | 2022 | 89621 | 0.080 |
Why?
|
| Apoptosis | 1 | 2015 | 1720 | 0.080 |
Why?
|
| Schools, Medical | 1 | 2008 | 134 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 761 | 0.070 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2015 | 40 | 0.060 |
Why?
|
| Oncogene Proteins | 2 | 2015 | 62 | 0.060 |
Why?
|
| Curriculum | 1 | 2008 | 568 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2015 | 818 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 730 | 0.040 |
Why?
|
| Antimutagenic Agents | 1 | 2015 | 7 | 0.030 |
Why?
|
| Cobalt | 1 | 2015 | 30 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 327 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 178 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 155 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 472 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 795 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 397 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 983 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 247 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 695 | 0.030 |
Why?
|
| Animals | 3 | 2018 | 27426 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2013 | 698 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 340 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2018 | 775 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 508 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1801 | 0.020 |
Why?
|
| Mice | 2 | 2015 | 11792 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1492 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1436 | 0.020 |
Why?
|
| Male | 3 | 2018 | 42558 | 0.020 |
Why?
|
| Rhode Island | 1 | 2008 | 10 | 0.020 |
Why?
|
| Mentors | 1 | 2008 | 88 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1555 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 2447 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 8273 | 0.020 |
Why?
|
| Students, Medical | 1 | 2008 | 421 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2008 | 785 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 3393 | 0.010 |
Why?
|